Swine Flu Information from PLoS and Google

PLoS Currents ... is a Google/PLoS collaborative effort using Knol to consolidate and organize info about H1N1 novel influenza flu.

The key goal of PLoS Currents is to accelerate scientific discovery by allowing researchers to share their latest findings and ideas immediately with the world's scientific and medical communities. Google Knol's features for community interaction, comment and discussion will enable commentary and conversations to develop around these findings. Given that the contributions to PLoS Currents are not peer-reviewed in detail, however, the results and conclusions must be regarded as preliminary. In time, it is therefore likely that PLoS Currents contributors will submit their work for publication in a formal journal, and the PLoS Journals will welcome these submissions.

All the details are here.

More like this

Yesterday PLoS and Google unveiled PLoS Currents: Influenza, a Google Knol hosted collection of rapid communications about the swine flu. In his blog post A new website for the rapid sharing of influenza research (also posted on the official Google blog), Dr.Harold Varmus explains: The key goal of…
At this very moment, PLoS Currents is expanding. Here is the information from PLoS: PLoS (Public Library of Science) is expanding PLoS Currents with the launch of two new sections, one on Huntington disease produced with support from CHDI Foundation, Inc., and the other entitled Evidence on…
It is infuriating how stodgy biomedical sciences are in terms of information sharing. It's not clear how much of this is bred of inherent conservatism, the pressures of a very competitive field or just plain technobackwardness. But while mathematics and physics have had preprint servers for years,…
John Lynch and Dr. Isis have already posted on the revelation that Elsevier published something, Australasian Journal of Bone and Joint Medicine, that looked and sounded like it was a medical journal but that turned out to have been fancy advertising for pharmaceuticals company Merck. The Scientist…